GeneWeave Biosciences (San Jose, CA) a development-stage molecular diagnostic company focused on using bacterial DNA for the detection of pathogens, closed a $12M Series A financing. Participants include Decheng Capital, Claremont Creek Ventures and X/Seed Capital.

Note: Closing out 1Q deals. Thanx for your patience as we play catch-up.